Get In Touch


Commonly Made Mistakes While Developing Global Value Dossiers



Top Strategy Mishaps of 2011-2012

NOVEL's team analyzed all product launches of 2011 and 2012 and developed a list of top strategy mishaps. This report also presents the lessons learned and implications for future products.

Read More

HEOR, Pricing and Marketing Strategy for Cancer Therapies

Oncology is the highest selling indication for pharmaceutical products. In a recent event NOVEL's team discussed the 10-years trends in oncology drug development.

Read More

Developing GVD for Pricing & Market Access Success

GVD is the single and central strategy resource for pricing and reimbursement of medical products. NOVEL's team recently hosted a webinar on strategies for developing GVDs.

Read More

Economic Models for HTAs, Payers and Providers

Economic models are becoming important tools for demonstrating economic value of new products. In our recent event we presented fundamentals of developing models, interactive design and easy-to-update features.

Read More